The host-immune response to SARS-CoV-2 infection varies. Some individuals have a strong immune response, resulting in a cytokine storm and debilitating physical symptoms. Others experience only mild symptoms, if any at all. Understanding the host-immune response to SARS-CoV-2 is important for vaccine development efforts, interpreting disease pathogenesis, and calibrating future pandemic control measures. This webinar will explore recent discoveries about the way the immune system responds to SARS-CoV-2 infection.
Topics to be covered
Speaker Information:
Daniela Weiskopf, PhD
Research Assistant Professor
Center for Infectious Disease and Vaccine Research
La Jolla Institute for Immunology
Alessandro Sette, DSc
Professor and Member
Center for Infectious Disease and Vaccine Research
La Jolla Institute for Immunology
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy